Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gram-positive bacterial cell wall and cytoplasmic membrane together form the cell envelope, a critical structure for maintaining bacterial viability and shape. The cell wall is composed of a thick, cross-linked peptidoglycan layer that provides structural rigidity and protects the bacterium from osmotic lysis (Silhavy et al., 2010). This layer is often associated with teichoic acids, which contribute to the cell's surface charge and play roles in pathogenesis. Beneath the peptidoglycan lies the cytoplasmic membrane, a selective permeability barrier that facilitates energy production and nutrient transport (Breijyeh et al., 2020). These structures are major targets for antimicrobial therapy because they are essential for bacteria and significantly different from human cellular components. Beta-lactam antibiotics, such as penicillins, inhibit the transpeptidase enzymes responsible for peptidoglycan cross-linking, while glycopeptides like vancomycin bind directly to cell wall precursors (Scheffers & Pinho, 2005). Additionally, lipopeptides like daptomycin target the cytoplasmic membrane, causing rapid depolarization and cell death (Taylor & Palmer, 2016).
Inhibition of peptidoglycan cross-linking (transpeptidation), binding to D-alanyl-D-alanine cell wall precursors, and disruption of the cytoplasmic membrane potential through pore formation or depolarization.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gram-positive bacterial cell wall and cytoplasmic membrane (None).